X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1917) 1917
Publication (233) 233
Book Chapter (20) 20
Patent (18) 18
Book / eBook (17) 17
Conference Proceeding (17) 17
Book Review (4) 4
Web Resource (3) 3
Data Set (2) 2
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (812) 812
cardiac & cardiovascular systems (804) 804
index medicus (653) 653
male (469) 469
female (345) 345
animals (332) 332
middle aged (271) 271
aged (215) 215
peripheral vascular disease (195) 195
atherosclerosis (156) 156
cardiology (146) 146
adult (139) 139
610 medicine & health (135) 135
endothelium (133) 133
risk factors (124) 124
nitric oxide (121) 121
hypertension (118) 118
treatment outcome (116) 116
clinic for cardiology (112) 112
mice (112) 112
risk (110) 110
rats (101) 101
endothelium, vascular - drug effects (99) 99
mortality (98) 98
disease (92) 92
cells, cultured (87) 87
hematology (86) 86
cardiovascular diseases (85) 85
myocardial-infarction (84) 84
cardiovascular (82) 82
abridged index medicus (79) 79
pharmacology & pharmacy (78) 78
acute myocardial-infarction (77) 77
heart (76) 76
hypertension - physiopathology (75) 75
time factors (75) 75
inflammation (74) 74
oxidative stress (70) 70
cardiovascular disease (69) 69
endothelium, vascular - physiopathology (69) 69
management (69) 69
nitric-oxide (69) 69
acute coronary syndromes (68) 68
mice, inbred c57bl (67) 67
prospective studies (67) 67
therapy (66) 66
endothelium, vascular - physiology (65) 65
analysis (63) 63
aged, 80 and over (62) 62
endothelium, vascular - metabolism (62) 62
blood pressure - drug effects (61) 61
cells (61) 61
medicine, general & internal (61) 61
muscle, smooth, vascular - drug effects (61) 61
outcomes (60) 60
european-society (59) 59
expression (59) 59
research (59) 59
thrombosis (59) 59
guidelines (58) 58
nitric-oxide synthase (57) 57
prognosis (56) 56
physiological aspects (55) 55
heart failure (54) 54
activation (53) 53
coronary heart disease (53) 53
in vitro techniques (53) 53
trial (53) 53
nitric oxide - physiology (52) 52
care and treatment (51) 51
electrocardiography (51) 51
follow-up studies (51) 51
medicine & public health (51) 51
myocardial infarction (51) 51
endothelin (49) 49
europe (49) 49
heart-failure (49) 49
cholesterol (48) 48
endothelin receptor antagonists (48) 48
vasodilation - drug effects (47) 47
double-blind method (46) 46
heart attacks (46) 46
relaxing factor (46) 46
nitric oxide - metabolism (45) 45
prevention (45) 45
570 life sciences; biology (44) 44
acute coronary syndrome (44) 44
blood pressure (44) 44
blood-pressure (44) 44
cardiovascular-disease (44) 44
coronary artery disease (44) 44
diagnosis (44) 44
rats, inbred wky (44) 44
acetylcholine (43) 43
acetylcholine - pharmacology (43) 43
association (43) 43
cardiac patients (43) 43
cardiomyopathy (42) 42
dysfunction (42) 42
health aspects (42) 42
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (7) 7
Online Resources - Online (3) 3
Robarts - Stacks (3) 3
UTL at Downsview - May be requested (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1920) 1920
German (48) 48
Spanish (17) 17
French (12) 12
Portuguese (5) 5
Japanese (4) 4
Polish (4) 4
Chinese (2) 2
Russian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cardiovascular Research, ISSN 0008-6363, 10/2019, Volume 115, Issue 12, pp. e125 - e126
Journal Article
Journal of Cardiovascular Medicine, ISSN 1558-2027, 10/2012, Volume 13, Issue 10, pp. 619 - 619
Journal Article
by Ghadri, Jelena R and Kato, Ken and Cammann, Victoria L and Gili, Sebastiano and Jurisic, Stjepan and Di Vece, Davide and Candreva, Alessandro and Ding, Katharina J and Micek, Jozef and Szawan, Konrad A and Bacchi, Beatrice and Bianchi, Rahel and Levinson, Rena A and Wischnewsky, Manfred and Seifert, Burkhardt and Schlossbauer, Susanne A and Citro, Rodolfo and Bossone, Eduardo and Münzel, Thomas and Knorr, Maike and Heiner, Susanne and D’Ascenzo, Fabrizio and Franke, Jennifer and Sarcon, Annahita and Napp, L. Christian and Jaguszewski, Milosz and Noutsias, Michel and Katus, Hugo A and Burgdorf, Christof and Schunkert, Heribert and Thiele, Holger and Bauersachs, Johann and Tschöpe, Carsten and Pieske, Burkert M and Rajan, Lawrence and Michels, Guido and Pfister, Roman and Cuneo, Alessandro and Jacobshagen, Claudius and Hasenfuß, Gerd and Karakas, Mahir and Koenig, Wolfgang and Rottbauer, Wolfgang and Said, Samir M and Braun-Dullaeus, Ruediger C and Banning, Adrian and Cuculi, Florim and Kobza, Richard and Fischer, Thomas A and Vasankari, Tuija and Airaksinen, K.E. Juhani and Opolski, Grzegorz and Dworakowski, Rafal and MacCarthy, Philip and Kaiser, Christoph and Osswald, Stefan and Galiuto, Leonarda and Crea, Filippo and Dichtl, Wolfgang and Empen, Klaus and Felix, Stephan B and Delmas, Clément and Lairez, Olivier and El-Battrawy, Ibrahim and Akin, Ibrahim and Borggrefe, Martin and Horowitz, John and Kozel, Martin and Tousek, Petr and Widimský, Petr and Gilyarova, Ekaterina and Shilova, Alexandra and Gilyarov, Mikhail and Winchester, David E and Ukena, Christian and Bax, Jeroen J and Prasad, Abhiram and Böhm, Michael and Lüscher, Thomas F and Ruschitzka, Frank and Templin, Christian
Journal of the American College of Cardiology, ISSN 0735-1097, 08/2018, Volume 72, Issue 8, pp. 874 - 882
Journal Article
by Mendes-Ferreira, P and Maia-Rocha, C and Adao, R and Lourenco, A. P and Moura, C and Pinho, S and Areias, J. C and De Keulenaer, G. W and Leite-Moreira, A. F and Bras-Silva, C and Holzhauser, L and Lindner, D and Jenke, A and Schultheiss, H.- P and Westermann, D and Skurk, C and Misaka, T and Suzuki, S and Miyata, M and Kobayashi, A and Saitoh, S and Takeishi, Y and Czolbe, M and Pekarek, V and Williams, T and Panther, F and Strassen, J and Ritter, O and Voss, S and Nef, H. M and Szardien, S and Troidl, C and Kojonazarov, B and Visser, D and Hoffmann, J and Willmer, M and Hamm, C. W and Moellmann, H and Ljubojevic, S and Sedej, S and Sacherer, M and Leitinger, G and Kockskaemper, J and Pieske, B and Vorobyeva, N. M and Dobrovolsky, A. B and Titaeva, E. V and Kirienko, A. I and Panchenko, E. P and Nakamura, R and Matsue, Y and Mizukami, A and Ohno, M and Suzuki, M and Matsumura, A and Hashimoto, Y and Rosiak, M and Postula, M and Kaplon-Cieslicka, A and Trzepla, E and Czlonkowski, A and Filipiak, K. J and Opolski, G and Kosior, D. A and Andersson, T and Nagy, P and Niazi, M and Nylander, S and Wallentin, L and Mendell, J and Johnson, L and Ridout, G and He, L and Chen, S and Petrkova, M and Schneiderova, P and Kriegova, E and Kolar, Z and Taborsky, M and Petrek, M and Khuseyinova, N and Schnabel, R and Zeller, T and Gori, T and Schulz, A and Espinola-Klein, C and Lackner, K. J and Blankenberg, S and Muenzel, T. F and Wild, P. S and Amabile, N and Cheng, S and Larson, M. G and Ghorbani, A and Mc Cabe, E and Griffin, G and Cohen, K. S and Tedgui, A and Boulanger, C. M and Wang, T. J and ... and on behalf of BBC ONE investigators and on behalf of WHICH? Trial Investigators and on behalf of EPES Acute Cardiac Care group and on behalf of Interventional Genetic Study Group in Cardiovascular Disease's and on behalf of HPS2-THRIVE Collaborative Group and on behalf of Advantageous Predictors of Acute Coronary Syndrome Evaluation (APACE) and on behalf of The Milan and New-Tokyo Registry and on behalf of SAFETY Investigators and on behalf of Advance CRT Investigators and on behalf of the ARVA Investigators and on behalf of TIMI Study Group and on behalf of REFINE ICD Investigators and on behalf of RO-AHFS Study Investigators and on behalf of The PASCAL Investigators and on behalf of the KorHF investigators and on behalf of TECAM and on behalf of The INSIGHT (R)XT investigators and on behalf of ATA-AF investigators and on behalf of The ODIN Participants and on behalf of CREDO-Kyoto Registry Cohort-2 Investigators and on behalf of AHEAD investigators and on behalf of the RESET investigators and on behalf of ABSORB Cohort B and on behalf of RE-LY Trial Investigators and on behalf of the CORONA Study Group and on behalf of PROTECTOME and on behalf of CoLaus Study and on behalf of OFRECE Study and on behalf of BBK Registry and on behalf of FAST-MI 2010 and on behalf of ATOLL investigators and on behalf of HARVEST study group and on behalf of Royal Brompton Hospital NIHR Cardiovascular Biomedical Research Unit and on behalf of the PROSPER study group and on behalf of MAGGIC study group and on behalf of the DANPACE Investigators and on behalf of German Conn's Registry and on behalf of NANOPLASTY group and on behalf of j-Cypher Registry and on behalf of NIL-CHF Study Investigators and on behalf of the FAST-MI 2010 investigators and on behalf of Competence Network Heart Failure and on behalf of Gothia Cardiovascular and on behalf of OPTIMISE CRT Investigators and on behalf of EVEREST trial investigators and on behalf of The Tohoku Acute Heart Failure Registry and on behalf of investigators of the national registry of ACS, Portuguese Society of Cardiology and on behalf of BIOSOLVE-I Investigators and on behalf of Department of Cardiology, Second Hospital of Tianjin Medical University and on behalf of THALES Registry Investigators and on behalf of STICH Investigators and on behalf of Young @ Heart Investigators and on behalf of PROCARDIS Consortium and on behalf of PEGASO and on behalf of The SWEDEHEART group and on behalf of BWGIC (Belgian Working Group of Invasive Cardiology and on behalf of Med in NRW and For The Topp Registry Investigators and on behalf of PRISON and on behalf of ARISTOTLE investigators and on behalf of the RACE II investigators and on behalf of Euro Heart Survey PCI registry investigators and on behalf of the SPICE investigators and on behalf of The ISAR REACT 4 Investigators and on behalf of Yokohama Medical Center Clinical Research group and on behalf of DiaRegis-Study-Group and on behalf of The RHYTHM-AF Study Scientific Committee and on behalf of the Korea Acute Myocardial Infarction Registry and on behalf of AMIS Plus Investigators and on behalf of SYNTAX Investigators and on behalf of Advantage Predictors of Acute Coronary Syndrome Evaluation and on behalf of CREATE investigator group and on behalf of Follow Your Heart Project and on behalf of SYNTAX Trial Investigators and on behalf of WELCOME Study Investigators and on behalf of Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK) investigators and on behalf of investigators of the national registry of ACS, Portugese Society of Cardiology and on behalf of EVITA-HF (Evidence Based Treatment - Heart Failure) and on behalf of ESTROFA and on behalf of Second Department of Internal Medicine and on behalf of Korea Acute Myocardial Infarction Registry and on behalf of PRAGUE-2 and on behalf of German Diabetes and Dialysis Study Investigators and on behalf of Hull LifeLab and on behalf of on behalf of the DYDA Investigators and on behalf of OFICA study group and on behalf of BASKET-PROVE and on behalf of the Triple-Site versus Standard Resynchronization Therapy Study (TRUST CRT) Investigators and on behalf of Scripps Translational Science Institute and on behalf of OMEGA study group and on behalf of PL-ACS Invastigators and on behalf of German Aortic Valve Therapy Registry and on behalf of TO BELIEVERS and on behalf of PREDICTION Study Group and on behalf of The REACH registry investigators and on behalf of PL-ACS Investigators and on behalf of KNHI and on behalf of Emerging Concepts in Cardiovascular Medicine and on behalf of CHART-2 Investigators and on behalf of the Fushimi AF Registry investigators and on behalf of Brasilian Heart Study Group and on behalf of Taiwan acute coronary syndrome full spetrum registry study group
European Heart Journal, ISSN 0195-668X, 08/2012, Volume 33, Issue suppl 1, pp. 339 - 653
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2015, Volume 373, Issue 10, pp. 929 - 938
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 11, pp. 2000 - 2000
Methods: After 7 weeks of high-fat high-cholesterol diet, DIO rats underwent RYGB or sham surgery. 
Cardiovascular | Internal Medicine | Obesity | Endothelium | Oxidative stress | Phosphorylation | Weight control | Peptides | Rodents | Surgery | Coronary vessels | Kinases
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2017, Volume 120, Issue 1, pp. S17 - S27
Journal Article
European Heart Journal, ISSN 0195-668X, 07/2014, Volume 35, Issue 27, pp. 1782 - 1791
Atherothrombosis is no longer considered solely a disorder of lipoprotein accumulation in the arterial wall. Rather, the initiation and progression of... 
Darapladib | Atherosclerosis | Inflammasome | Inflammation | Colchicine | Salsalate | C reactive protein | Canakinumab | Methotrexate | Interleukin-6 | C-REACTIVE PROTEIN | FUTURE MYOCARDIAL-INFARCTION | CARDIAC & CARDIOVASCULAR SYSTEMS | INTERLEUKIN-1 RECEPTOR ANTAGONIST | RANDOMIZED CLINICAL-TRIAL | SECRETORY PHOSPHOLIPASE A | ACUTE CORONARY SYNDROME | APPARENTLY HEALTHY-MEN | REVERSE CHOLESTEROL TRANSPORT | PLACEBO-CONTROLLED TRIAL | TYPE-2 DIABETES-MELLITUS | Hydroxychloroquine - therapeutic use | Interleukin-6 - antagonists & inhibitors | NLR Family, Pyrin Domain-Containing 3 Protein | Colchicine - therapeutic use | Humans | Cell Adhesion Molecules - antagonists & inhibitors | Methotrexate - therapeutic use | Sirtuins - therapeutic use | Vaccination - methods | Lipoproteins, HDL - drug effects | Interleukin-1 - physiology | Interleukin-6 - physiology | Anti-Inflammatory Agents - therapeutic use | Interleukin-1 - antagonists & inhibitors | Leukotriene Antagonists - therapeutic use | Carrier Proteins - physiology | Adaptive Immunity - physiology | Phospholipase A2 Inhibitors - therapeutic use | Atherosclerosis - drug therapy | Serpins - therapeutic use | C-Reactive Protein - physiology | Antioxidants - therapeutic use | Tumor Necrosis Factor-alpha - drug effects | Signal Transduction - drug effects | Tumor Necrosis Factor-alpha - physiology | Thrombosis - drug therapy | Receptors, Interleukin-1 - antagonists & inhibitors | Review
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 12/2016, Volume 375, Issue 26, pp. 2519 - 2529
BACKGROUND The cardiovascular safety of celecoxib, as compared with nonselective nonsteroidal anti-inflammatory drugs (NSAIDs), remains uncertain. METHODS... 
MEDICINE, GENERAL & INTERNAL | PAIN | METAANALYSIS | OSTEOARTHRITIS | CLINICAL-TRIAL | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | Celecoxib - adverse effects | Naproxen - adverse effects | Ibuprofen - therapeutic use | Humans | Middle Aged | Male | Risk | Celecoxib - therapeutic use | Naproxen - therapeutic use | Cyclooxygenase 2 Inhibitors - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Arthritis - drug therapy | Cyclooxygenase 2 Inhibitors - therapeutic use | Intention to Treat Analysis | Kidney Diseases - chemically induced | Cardiovascular Diseases - mortality | Female | Aged | Cardiovascular Diseases - chemically induced | Ibuprofen - adverse effects | Gastrointestinal Diseases - chemically induced | Care and treatment | Safety and security measures | Naproxen | Ibuprofen | Dosage and administration | Arthritis | Celecoxib | Diagnosis | Cardiovascular diseases | Risk factors | Cardiovascular disease | Side effects | Nonsteroidal anti-inflammatory drugs | Pain management | Myocardial infarction | Fees & charges | Hemorrhage | Pain | Motivation | Analgesics | Safety | Drug dosages | Cerebral infarction | Statistical analysis | Anemia | Committees | FDA approval | Patients | Manuscripts | Rheumatoid arthritis | Collaboration | Osteoarthritis | Pharmaceuticals
Journal Article